DETERMINING THE SAFETY AND EFFICACY OF PROPHYLACTIC DEFIBROTIDE ADMINISTRATION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH SICKLE CELL DISEASE FOLLOWING MYELOIMMUNOABLATIVE CONDITIONING (MAC) AND HAPLOIDENTICAL STEM CELL TRANSPLANTATION UTILIZING CD34+SELECTION AND T-CELL (CD3) ADDBACK (IND127812)

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION(2020)

引用 0|浏览30
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要